Cargando…

Beneficiality of combined levetiracetam, clonazepam for myoclonus in MERRF requires further confirmation

Detalles Bibliográficos
Autor principal:	Finsterer, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415986/ https://www.ncbi.nlm.nih.gov/pubmed/30807362 http://dx.doi.org/10.1097/CM9.0000000000000042

Ejemplares similares

Photosensitive Epilepsy and Polycystic Ovary Syndrome as Manifestations of MERRF
por: Finsterer, Josef
Publicado: (2020)

Stimulus-induced myoclonus treated effectively with clonazepam in genetically confirmed Coffin–Lowry syndrome()
por: Arslan, Elif Acar, et al.
Publicado: (2014)

Diagnosing Kearns-Sayre Syndrome Requires Genetic Confirmation
por: Finsterer, Josef, et al.
Publicado: (2016)

Pathogenicity of the Homoplasmic m.8701A>G Variant Requires Confirmation
por: Finsterer, Josef, et al.
Publicado: (2016)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
por: Cho, Jae Wook, et al.
Publicado: (2014)

Multifocal myoclonus as a presentation of levetiracetam toxicity
por: Bou Nasif, Mei, et al.
Publicado: (2021)

Antimyoclonic Effect of Levetiracetam and Clonazepam Combined Treatment on Myoclonic Epilepsy with Ragged-Red Fiber Syndrome with m.8344A>G Mutation
por: Su, Li-Jun, et al.
Publicado: (2018)

Generation of Normal Values for Respiratory Muscle Force Requires That the Control Group Be Examined Neurologically
por: Finsterer, Josef
Publicado: (2023)

Diagnosis of Kearns–Sayre syndrome requires genetic confirmation
por: Finsterer, Josef
Publicado: (2023)

Diagnosis of Kearns–Sayre syndrome requires genetic confirmation
por: Finsterer, Josef
Publicado: (2023)

Prospective studies are required for assessing the outcome of a SARS-CoV-2 infection based on the symptoms at onset
por: Finsterer, Josef
Publicado: (2023)

Diagnosis of Kearns-Sayre Syndrome Requires Comprehensive Work-up
por: Finsterer, Josef, et al.
Publicado: (2016)

Unmasking fibromyalgia as a mitochondrial disorder requires search for more than a single variant or single mtDNA deletions
por: Finsterer, Josef
Publicado: (2020)

Letter to the Editor: Assessing the Effect of Thrombectomy up to 24h After Onset of Stroke Requires Large, Prospective, International Studies
por: Finsterer, Josef
Publicado: (2023)

Botulinum Toxin A for Treatment of Diaphragmatic Myoclonus
por: He, Yi-Jing, et al.
Publicado: (2017)

Pancytopenia associated with clonazepam
por: Bautista-Quach, Marnelli A, et al.
Publicado: (2010)

Histochemical and molecular genetic study of MELAS and MERRF in Korean patients.
por: Kim, Dae Seong, et al.
Publicado: (2002)

Reversible dysphagia due to gabapentin-induced jaw myoclonus
por: Hui, Chun-Him, et al.
Publicado: (2019)

Assessment of the phenotype genotype variability and correlation in m.3243A > G mutation carriers requires prospective studies
por: Finsterer, Josef, et al.
Publicado: (2016)

SARS-CoV-2 associated acute, motor and sensory, axonal neuropathy requires comprehensive diagnostic work-up
por: Finsterer, Josef, et al.
Publicado: (2023)

A Case Report of Excessive Use of Clozapine Combined With Clonazepam
por: Li, Wei, et al.
Publicado: (2022)

Assessing beneficial or side effects of COVID-vaccinations requires personal rather than electronic investigations
por: Finsterer, Josef
Publicado: (2022)

Early Use of Norepinephrine for Sepsis: Promising Results That Require Confirmation
por: El Bèze, Nathan, et al.
Publicado: (2019)

Late-onset Juvenile Myoclonic Epilepsy or Frontal Lobe Epilepsy with Myoclonus
por: Zhang, Xin-Yue, et al.
Publicado: (2016)

Brain-Targeted Nasal Clonazepam Microspheres
por: Shaji, J., et al.
Publicado: (2009)

Clonazepam in the treatment of essential palatal tremors
por: Pandurangi, Aditya A., et al.
Publicado: (2012)

Clonazepam: Lack of efficacy: case report
Publicado: (2022)

Pulsatile tinnitus: treatment with clonazepam and propranolol
por: Albertino, Sergio, et al.
Publicado: (2015)

Levetiracetam Induced Urticarial Vasculitis: A Preliminary Report
por: Mangal, Sonia S, et al.
Publicado: (2014)

Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome
por: Wiegand, Sarah E., et al.
Publicado: (2021)

Distal weakness with respiratory insufficiency caused by the m.8344A > G “MERRF” mutation
por: Blakely, Emma L., et al.
Publicado: (2014)

A typical case of myoclonic epilepsy with ragged red fibers (MERRF) and the lessons learned
por: Chandra, SR, et al.
Publicado: (2015)

Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023)

Design and Evaluation of Fast Dissolving Tablets of Clonazepam
por: Shirsand, S. B., et al.
Publicado: (2008)

Clonazepam/gabapentin: Lack of efficacy: case report
Publicado: (2022)

Madelung lipomatosis presenting as a manifestation of myoclonic epilepsy with ragged red fibers (MERRF) syndrome
por: Gilson, Robert Christopher, et al.
Publicado: (2018)

Is the MT-TN variant m.5703G>A truly causative for myoclonic epilepsy with ragged red fibers syndrome plus?
por: Finsterer, Josef
Publicado: (2019)

SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection
por: Finsterer, Josef
Publicado: (2020)

The metabolic hypothesis is more likely than the epileptogenic hypothesis to explain stroke-like lesions
por: Finsterer, Josef
Publicado: (2020)

Asymmetric parietal and temporal lobe atrophy due to the variant m.8363G>A in transfer ribonucleic acid (Lysine)
por: Finsterer, Josef
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nfa9f7kiqav5oab9pn0rin1nu2